This is the complete third paragraph of the PR:
Post# of 148170
(Total Views: 511)
Posted On: 12/09/2021 10:12:48 AM
This is the complete third paragraph of the PR:
"If approved by the FDA, patients in this trial will be randomized in a 1:1 ratio to receive up to four doses of (<<700 mg leronlimab with standard of care>>
or {***placebo with standard of care***} administered by 30-minute IV infusion weekly over a four-week treatment period."
I've added my own parentheses/etc to indicate my impression of the sentence.
This is like the math rules: 5 + 3 x 4 = 60, not 32, because by rule, you perform the multiplication first, then the addition.
There is no SOC which involves a 30 minute IV infusion once per week. SOC will continue for all patients, with the usual established or customized dosing, separate from administering LL or placebo. IMO.
"If approved by the FDA, patients in this trial will be randomized in a 1:1 ratio to receive up to four doses of (<<700 mg leronlimab with standard of care>>
or {***placebo with standard of care***} administered by 30-minute IV infusion weekly over a four-week treatment period." I've added my own parentheses/etc to indicate my impression of the sentence.
This is like the math rules: 5 + 3 x 4 = 60, not 32, because by rule, you perform the multiplication first, then the addition.
There is no SOC which involves a 30 minute IV infusion once per week. SOC will continue for all patients, with the usual established or customized dosing, separate from administering LL or placebo. IMO.
(10)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼